[¾÷°è¿ì´ë/¼º°ú±ÞÁ¦°ø ]

T cell engager(ÀÌÁßÇ×üTCE) ¿¬±¸

KPI¿¡ µû¸¥ ¼º°ú±ÞÁö±Þ, ¾÷¿ì´ë ´ë¿ì 
 

¸ðÁýºÎ¹® ¹× ÀÚ°Ý¿ä°Ç

¸ðÁýºÎ¹® ´ã´ç¾÷¹« ÀÚ°Ý¿ä°Ç Àοø

¾÷°è¿ì´ë /

T cell engager(ÀÌÁßÇ×ü/TCE)

[´ã´ç¾÷¹«]

- T cell engager(TCE) In vitro assay ¼öÇà ¹× Ç÷§Æû ±¸Ãà: cancer cell culture, immune cell(PBMC/T cell) handling, co-culture Á¶°Ç ÃÖÀûÈ­
- In vitro assay ¼öÇà ¹× Ç÷§Æû ±¸Ãà: cancer cell culture, immune cell(PBMC/T cell) handling, co-culture Á¶°Ç ÃÖÀûÈ­
- In vitro killing/effector ±â´ÉÆò°¡: cytotoxicity assay
- µ¥ÀÌÅÍ ÇØ¼® ¹× ÀÇ»ç°áÁ¤ ¸®µù: ½ÇÇè ¼³°è¡æ°á°ú ÇØ¼®¡æ´ÙÀ½ ¾×¼Ç(°³¼±/Áß´Ü/¿ì¼±¼øÀ§)±îÁö ÁÖµµ

[ÀÚ°Ý¿ä°Ç]

°æ·Â: ½ÅÀÔ/°æ·Â 4³â¡è(¼®»çÀÌ»ó)
- »ý¹°ÇÐ/¸é¿ªÇÐ/¾àÇÐ/»ý¸í°øÇÐ µî °ü·ÃÀü°øÀÚ.
- °æ·Â 5³â ³»¿Ü, ¸é¿ªÇ×¾Ï/Ç×ü ±â¹Ý ¹ÙÀÌ¿À ¿¬±¸ °æÇè º¸À¯
- Cancer cell culture ¼÷·Ã ¹× ¼¼Æ÷ ±â¹Ý ½ÇÇè ¼³°è¡¤¼öÇà ´É·Â
- In vitro killing assay °æÇè Çʼö: T cell/PBMC co-culture ±â¹Ý cytotoxicity Æò°¡(Á¤·® readout Æ÷ÇÔ) °æÇè
- Flow cytometry ±â¹Ý ¸é¿ª¼¼Æ÷ ºÐ¼®(activation/exhaustion marker µî) ¹× µ¥ÀÌÅÍ ÇØ¼® ¿ª·®
- ½ÇÇè ÀçÇö¼º/ǰÁú¿¡ ´ëÇÑ ³ôÀº ±âÁØÀ¸·Î ½ÇÇè Á¶°Ç ÃÖÀûÈ­ ¹× Æ®·¯ºí½´ÆÃÀ» ³¡±îÁö ¼öÇàÇÒ ¼ö ÀÖ´Â ºÐ
- ¿­Á¤ÀûÀ̰í ÁÖµµÀûÀΠŵµ: °úÁ¦ ¿À³Ê½ÊÀ» °®°í ½º½º·Î ¸ñÇ¥¸¦ Á¤ÀÇ¡¤ÃßÁøÇϸç, ºü¸£°Ô ÇнÀÇÏ°í ÆÀÀ» ¼³µæ/Á¤·ÄÇÒ ¼ö ÀÖ´Â ºÐ


[¿ì´ë»çÇ×]

- T cell engager(TCE) ¼öÇà °æÇè(¼³°è¡æin vitro POC¡æ¸®µå ÃÖÀûÈ­ Áß 1°³ ÀÌ»ó ´Ü°è¿¡¼­ ÁÖµµÀû ¿ªÇÒ)

- ´Ù¾çÇÑ TCE Æ÷¸Ë/±âÀü ºñ±³(affinity tuning, CD3 arm ¼³°è/¾ÈÀü¼º °í·Á µî) °æÇè

- MOA °íµµÈ­ °æÇè(¿¹: phospho-flow, activation signaling, ¸é¿ª½Ã³À½º/engagement Á¤·®, target density-dependent activity µî)

- Cytokine release/over-activation risk °üÁ¡ÀÇ in vitro ¾ÈÀü¼º Æò°¡ °æÇè

- ³í¹®/ƯÇã µî ¿¬±¸ ¼º°ú º¸À¯

-  TCE ¹× ¸é¿ªÇ×¾ÏÇ×ü FDA ¹× MFDS IND packaging °æ·Â

- ¹Ú»ç±Þ ¿ì´ë

0 ¸í

±Ù¹«Á¶°Ç

  • °í¿ëÇüÅÂ: Á¤±ÔÁ÷(¼ö½À±â°£3°³¿ù)
  • ±Þ¿©Á¶°Ç: ȸ»ç³»±Ô

ÀüÇü´Ü°è ¹× Á¦Ãâ¼­·ù

  • ÀüÇü´Ü°è: ¼­·ùÀüÇü > ¸éÁ¢ÁøÇà > 2Â÷¸éÁ¢ÁøÇà > ÃÖÁ¾ÇÕ°Ý
  • Ãß°¡ Á¦Ãâ¼­·ù
    Æ÷Æ®Æú¸®¿À ¶Ç´Â°æ·Â±â¼ú¼­ ¿ì´ë

Á¢¼ö¹æ¹ý

ä¿ë½Ã

  • Á¢¼ö¹æ¹ý: ÀÎÅ©·çÆ® Á¢¼ö
  • Á¢¼ö¾ç½Ä: ÀÎÅ©·çÆ® À̷¼­

±âŸ À¯ÀÇ»çÇ×

  • ÀÔ»çÁö¿ø¼­ ¹× Á¦Ãâ¼­·ù¿¡ ÇãÀ§»ç½ÇÀÌ ÀÖÀ» °æ¿ì ä¿ëÀÌ Ãë¼ÒµÉ ¼ö ÀÖ½À´Ï´Ù.

00